WHO ICTRP trial

Evaluation of hyperbaric ropivacaine drug effect when given in single shot…

CTRI/2025/11/097360 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/11/097360
Public title Evaluation of hyperbaric ropivacaine drug effect when given in single shot spinal anesthesia versus low dose combined spinal epidural anaesthesia in patient groups having cardiac disease and undergoing hip fracture surgery.
Scientific title Evaluation of efficacy and safety of hyperbaric ropivacaine in single dose spinal versus low dose combined spinal epidural anaesthesia among cardiac patients undergoing hip fracture surgery: A randomized comparative study - Nil
Primary sponsor Maharana Bhupal Government Hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries India
Conditions Health Condition 1: M899- Disorder of bone, unspecified Health Condition 2: W108- Fall (on) (from) other stairs andsteps Health Condition 3: W06- Fall from bed Health Condition 4: W07- Fall from chair Health Condition 5: W15- Fall from…
Interventions Intervention1: To compare the incidence of hypotension: To determine the incidence of intraoperative hypotension for 150 minutes in patients receiving 0.75% hyperbaric ropivacaine in single shot spinal anesthesia compared with combined…
Registration date Nov 13, 2025
Target size 140
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations